| HLA-B* 5701 screening for hypersensitivity to abacavir S Mallal, E Phillips, G Carosi, JM Molina, C Workman, J Tomažič, ... New England Journal of Medicine 358 (6), 568-579, 2008 | 2136 | 2008 |
| Fulminant myocarditis with combination immune checkpoint blockade DB Johnson, JM Balko, ML Compton, S Chalkias, J Gorham, Y Xu, ... New England Journal of Medicine 375 (18), 1749-1755, 2016 | 1983 | 2016 |
| Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans J Mateus, A Grifoni, A Tarke, J Sidney, SI Ramirez, JM Dan, ZC Burger, ... Science 370 (6512), 89-94, 2020 | 1144 | 2020 |
| T cells from patients with Parkinson’s disease recognize α-synuclein peptides D Sulzer, RN Alcalay, F Garretti, L Cote, E Kanter, J Agin-Liebes, C Liong, ... Nature 546 (7660), 656-661, 2017 | 733 | 2017 |
| SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron A Tarke, CH Coelho, Z Zhang, JM Dan, ED Yu, N Methot, NI Bloom, ... Cell 185 (5), 847-859. e11, 2022 | 652 | 2022 |
| Predisposition to abacavir hypersensitivity conferred by HLA-B* 5701 and a haplotypic Hsp70-Hom variant AM Martin, D Nolan, S Gaudieri, CA Almeida, R Nolan, I James, ... Proceedings of the National Academy of Sciences 101 (12), 4180-4185, 2004 | 563 | 2004 |
| mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach A Banerji, PG Wickner, R Saff, CA Stone Jr, LB Robinson, AA Long, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (4), 1423-1437, 2021 | 514 | 2021 |
| Antibiotic allergy KG Blumenthal, JG Peter, JA Trubiano, EJ Phillips The Lancet 393 (10167), 183-198, 2019 | 507 | 2019 |
| Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases A Tarke, J Sidney, CK Kidd, JM Dan, SI Ramirez, ED Yu, J Mateus, ... Cell Reports Medicine 2 (2), 2021 | 480 | 2021 |
| Maintaining safety with SARS-CoV-2 vaccines MC Castells, EJ Phillips New England Journal of Medicine 384 (7), 643-649, 2021 | 467 | 2021 |
| Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire DA Ostrov, BJ Grant, YA Pompeu, J Sidney, M Harndahl, S Southwood, ... Proceedings of the National Academy of Sciences 109 (25), 9959-9964, 2012 | 462 | 2012 |
| High sensitivity of human leukocyte antigen-b* 5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients M Saag, R Balu, E Phillips, P Brachman, C Martorell, W Burman, B Stancil, ... Clinical infectious diseases 46 (7), 1111-1118, 2008 | 435 | 2008 |
| One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome CM Tansey, M Louie, M Loeb, WL Gold, MP Muller, JA de Jager, ... Archives of internal medicine 167 (12), 1312-1320, 2007 | 404 | 2007 |
| Predisposition to nevirapine hypersensitivity associated with HLA-DRB1* 0101 and abrogated by low CD4 T-cell counts AM Martin, D Nolan, I James, P Cameron, J Keller, C Moore, E Phillips, ... Aids 19 (1), 97-99, 2005 | 384 | 2005 |
| Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin … AE Simor, E Phillips, A McGeer, A Konvalinka, M Loeb, HR Devlin, A Kiss Clinical Infectious Diseases 44 (2), 178-185, 2007 | 361 | 2007 |
| Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized CA Stone Jr, Y Liu, MV Relling, MS Krantz, AL Pratt, A Abreo, JA Hemler, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (5), 1533-1540. e8, 2019 | 357 | 2019 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 286 | 2005 |
| α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease CS Lindestam Arlehamn, R Dhanwani, J Pham, R Kuan, A Frazier, ... Nature communications 11 (1), 1875, 2020 | 283 | 2020 |
| Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update EJ Phillips, C Sukasem, M Whirl‐Carrillo, DJ Müller, HM Dunnenberger, ... Clinical Pharmacology & Therapeutics 103 (4), 574-581, 2018 | 254 | 2018 |
| Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response KD White, WH Chung, SI Hung, S Mallal, EJ Phillips Journal of Allergy and Clinical Immunology 136 (2), 219-234, 2015 | 252 | 2015 |
